These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 19270439

  • 1. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
    Piehl-Aulin K, Jones I, Lindvall B, Magnuson A, Abdel-Halim SM.
    Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
    [Abstract] [Full Text] [Related]

  • 2. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F, Kirdar S, Karul AB, Ceylan E.
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [Abstract] [Full Text] [Related]

  • 3. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients.
    Crul T, Spruit MA, Gayan-Ramirez G, Quarck R, Gosselink R, Troosters T, Pitta F, Decramer M.
    Eur J Clin Invest; 2007 Nov; 37(11):897-904. PubMed ID: 17883420
    [Abstract] [Full Text] [Related]

  • 4. Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease.
    Ju CR, Chen RC.
    Respir Med; 2012 Jan; 106(1):102-8. PubMed ID: 21840694
    [Abstract] [Full Text] [Related]

  • 5. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A, Schreder M, Wolzt M, Saliba S, Kapiotis S, Eickhoff P, Burghuber OC.
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [Abstract] [Full Text] [Related]

  • 6. [Systemic inflammation during exacerbations of chronic obstructive pulmonary disease].
    Malo O, Sauleda J, Busquets X, Miralles C, Agustí AG, Noguera A.
    Arch Bronconeumol; 2002 Apr; 38(4):172-6. PubMed ID: 11953269
    [Abstract] [Full Text] [Related]

  • 7. Circulating visfatin in chronic obstructive pulmonary disease.
    Liu X, Ji Y, Chen J, Li S, Luo F.
    Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239
    [Abstract] [Full Text] [Related]

  • 8. [Serum ghrelin, IL-6 and TNF-α levels in patients with chronic obstructive pulmonary disease.].
    Deveci Y, Deveci F, Ilhan N, Karaca I, Turgut T, Muz MH.
    Tuberk Toraks; 2010 Apr; 58(2):162-72. PubMed ID: 20865569
    [Abstract] [Full Text] [Related]

  • 9. Exercise-induced systemic effects in muscle-wasted patients with COPD.
    Van Helvoort HA, Heijdra YF, Thijs HM, Viña J, Wanten GJ, Dekhuijzen PN.
    Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
    [Abstract] [Full Text] [Related]

  • 10. The role of serum leptin and tumor necrosis factor-alpha in malnutrition of male chronic obstructive pulmonary disease patients.
    Yang YM, Sun TY, Liu XM.
    Chin Med J (Engl); 2006 Apr 20; 119(8):628-33. PubMed ID: 16635406
    [Abstract] [Full Text] [Related]

  • 11. Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement.
    Koehler F, Doehner W, Hoernig S, Witt C, Anker SD, John M.
    Int J Cardiol; 2007 Jun 25; 119(1):83-9. PubMed ID: 17064790
    [Abstract] [Full Text] [Related]

  • 12. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease.
    Kirdar S, Serter M, Ceylan E, Sener AG, Kavak T, Karadağ F.
    Scand J Clin Lab Invest; 2009 Jun 25; 69(2):219-24. PubMed ID: 18946779
    [Abstract] [Full Text] [Related]

  • 13. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin.
    Lee TM, Lin MS, Chang NC.
    Am J Cardiol; 2008 Feb 15; 101(4):530-5. PubMed ID: 18312772
    [Abstract] [Full Text] [Related]

  • 14. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
    Bircan A, Gokirmak M, Kilic O, Ozturk O, Akkaya A.
    Med Princ Pract; 2008 Feb 15; 17(3):202-8. PubMed ID: 18408388
    [Abstract] [Full Text] [Related]

  • 15. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters.
    Calikoglu M, Sahin G, Unlu A, Ozturk C, Tamer L, Ercan B, Kanik A, Atik U.
    Respiration; 2004 Feb 15; 71(1):45-50. PubMed ID: 14872110
    [Abstract] [Full Text] [Related]

  • 16. Associations between BODE index and systemic inflammatory biomarkers in COPD.
    Gaki E, Kontogianni K, Papaioannou AI, Bakakos P, Gourgoulianis KI, Kostikas K, Alchanatis M, Papiris S, Loukides S.
    COPD; 2011 Dec 15; 8(6):408-13. PubMed ID: 22149400
    [Abstract] [Full Text] [Related]

  • 17. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
    Kunisaki KM, Rice KL, Janoff EN, Rector TS, Niewoehner DE.
    Ther Adv Respir Dis; 2008 Apr 15; 2(2):55-64. PubMed ID: 19124359
    [Abstract] [Full Text] [Related]

  • 18. Correlates of erectile dysfunction in moderate-to-severe chronic obstructive pulmonary disease patients.
    Karadag F, Ozcan H, Karul AB, Ceylan E, Cildag O.
    Respirology; 2007 Mar 15; 12(2):248-53. PubMed ID: 17298458
    [Abstract] [Full Text] [Related]

  • 19. Systemic inflammation in chronic obstructive pulmonary disease and asthma: Similarities and differences.
    Higashimoto Y, Yamagata Y, Taya S, Iwata T, Okada M, Ishiguchi T, Sato H, Itoh H.
    Respirology; 2008 Jan 15; 13(1):128-33. PubMed ID: 18197923
    [Abstract] [Full Text] [Related]

  • 20. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M.
    Clin Respir J; 2009 Apr 15; 3(2):121-2. PubMed ID: 20298391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.